Rathin C. Das, PhD

Rathin Das, PhD, MBA, is chief executive officer of Synergys Biotherapeutics, 1945 Arbol Grande, Walnut Creek, CA 94595, rathindas2009@gmail.com

The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.

Innovative products and a range of indications drive the therapeutic antibody market.